VUNO is a pioneering healthcare technology company that develops AI-driven medical solutions, specializing in biosignal analysis and medical imaging to assist clinicians. Its offerings include VUNO Med DeepCARS for early cardiac arrest risk assessment and VUNO Med Chest X-ray Triage for detecting chest abnormalities, with applications in inpatient monitoring, radiology, and critical care. The company is headquartered in Marlborough, Massachusetts, and markets its solutions to healthcare professionals to improve patient outcomes and reduce costs through AI-enabled diagnostics and decision support.
No recent news for this company.